Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -33.23%12.57M | 28.17%16.87M | -19.87%58.48M | -30.54%11.09M | -23.69%15.31M | -5.07%18.82M | -22.42%13.17M | 9.50%72.99M | -12.39%15.96M | 5.03%20.06M |
| Cost of revenue | -29.48%20.79M | 13.28%29.48M | ||||||||
| Gross profit | -13.36%37.69M | -23.69%15.31M | 7.08%43.5M | -13.36M | 20.06M | |||||
| Operating expense | -15.30%14.59M | 20.57%18.3M | -4.39%41.16M | -23.99%13.73M | -10.87%15.67M | -7.00%17.22M | -16.93%15.18M | 8.48%43.05M | 422.77%18.06M | 5.57%17.58M |
| Selling and administrative expenses | ---- | ---- | -4.57%41.22M | ---- | ---- | ---- | ---- | 7.30%43.2M | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | -5.24%1.65M | ---- | ---- | ---- | ---- | 21.82%1.74M | ---- | ---- |
| -General and administrative expense | ---- | ---- | -4.54%39.58M | ---- | ---- | ---- | ---- | 6.77%41.46M | ---- | ---- |
| Depreciation and amortization | -2.48%2.79M | -1.46%2.77M | -8.87%10.32M | 6.49%2.81M | 10.00%2.85M | 11.03%2.86M | 11.58%2.81M | --11.33M | --2.64M | 5.37%2.59M |
| -Depreciation | -2.48%2.79M | -1.46%2.77M | -8.87%10.32M | 6.49%2.81M | 10.00%2.85M | 11.03%2.86M | 11.58%2.81M | --11.33M | --2.64M | 5.37%2.59M |
| Other operating expenses | -17.79%11.81M | 25.66%15.54M | 80,000.00%801K | -21.45%12.12M | -15.74%12.96M | -13.10%14.37M | -21.57%12.37M | -94.12%1K | 140.55%15.43M | 7.72%15.38M |
| Total other operating income | 77.78%16K | 500.00%12K | 489.73%861K | 238.31%1.2M | -63.48%145K | -98.49%9K | -88.89%2K | -75.17%146K | -283.83%-864K | 341.11%397K |
| Operating profit | -225.61%-2.02M | 29.11%-1.43M | -871.56%-3.47M | -25.88%-2.64M | -114.27%-355K | 22.15%1.61M | -54.73%-2.01M | -52.03%450K | 5.07%-2.1M | 1.30%2.49M |
| Net non-operating interest income (expenses) | 9.96%-1.29M | 8.04%-1.32M | 7.35%-5.61M | -4.64%-1.51M | 17.26%-1.25M | 6.99%-1.44M | 8.03%-1.43M | 1.19%-6.06M | 1.16%-1.44M | 12.65%-1.51M |
| Non-operating interest income | 600.00%7K | 51.85%41K | -53.57%39K | --0 | -8.33%11K | -96.30%1K | -30.77%27K | 162.50%84K | -77.78%6K | 300.00%12K |
| Non-operating interest expense | -9.53%1.3M | -6.93%1.36M | -7.98%5.65M | 4.21%1.51M | -17.19%1.26M | -8.53%1.44M | -8.59%1.46M | -0.34%6.14M | -2.56%1.45M | -12.11%1.52M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -34.02%64K | 193.27%97K | ||||||||
| Less:Write off | ---- | ---- | 34.02%-64K | ---- | ---- | ---- | ---- | -193.27%-97K | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -2,057.99%-3.31M | 20.35%-2.74M | -63.73%-9.02M | -17.23%-4.15M | -264.55%-1.61M | 173.48%169K | -20.55%-3.44M | -4.04%-5.51M | 6.17%-3.54M | 34.62%976K |
| Income tax | 0 | 1,860.00%98K | -513.95%-178K | -572.80%-841K | 781.08%652K | -95.31%3K | -82.76%5K | -60.19%43K | 2.34%-125K | 7.25%74K |
| Net income | -2,093.37%-3.31M | 17.63%-2.84M | -59.25%-8.84M | 3.10%-3.31M | -350.33%-2.26M | 156.46%166K | -19.51%-3.45M | -2.76%-5.55M | 6.31%-3.42M | 37.50%902K |
| Net income continuous operations | -2,093.37%-3.31M | 17.63%-2.84M | -59.25%-8.84M | 3.10%-3.31M | -350.33%-2.26M | 156.46%166K | -19.51%-3.45M | -2.76%-5.55M | 6.31%-3.42M | 37.50%902K |
| Noncontrolling interests | -134.18%-54K | 28.24%-94K | -1,140.00%-2.13M | -721.41%-2.21M | 95.83%47K | 551.43%158K | 5.76%-131K | 132.03%205K | 159.07%355K | 24K |
| Net income attributable to the company | -40,787.50%-3.26M | 17.21%-2.75M | -16.54%-6.71M | 70.72%-1.1M | -362.53%-2.31M | 103.09%8K | -20.79%-3.32M | -20.87%-5.76M | -23.84%-3.77M | 33.84%878K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -40,787.50%-3.26M | 17.21%-2.75M | -16.54%-6.71M | 70.72%-1.1M | -362.53%-2.31M | 103.09%8K | -20.79%-3.32M | -20.87%-5.76M | -23.84%-3.77M | 33.84%878K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -25,200.00%-0.0025 | 17.24%-0.0024 | -15.69%-0.0059 | 72.73%-0.0009 | -350.00%-0.002 | 104.35%0 | -20.83%-0.0029 | -21.43%-0.0051 | -22.22%-0.0033 | 33.33%0.0008 |
| Diluted earnings per share | -25,200.00%-0.0025 | 17.24%-0.0024 | -15.69%-0.0059 | 72.73%-0.0009 | -350.00%-0.002 | 104.35%0 | -20.83%-0.0029 | -21.43%-0.0051 | -22.22%-0.0033 | 33.33%0.0008 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.